The Food and Drug Administration (FDA) will reopen public comment on a proposed rule clarifying when products made or derived from tobacco should be regulated as drugs, devices or combination products, the agency said.

The initial 60-day period for comments to the FDA’s Center for Tobacco Products ended 24 Nov. Additional information, including new dates, will be released when the Federal Register notice becomes available, the agency said.